Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Iranian Journal of Pharmaceutical Research : IJPR|February 14, 2014
Pharmacists remuneration models in iran and selected countries: a comparative studyAmir Hashemi-Meshkini, Khosro Keshavarz, Shekoufeh Nikfar, et al.
Journal of Research in Pharmacy Practice|October 24, 2022
Evaluation of COVID-19 Treatments in Iran in Comparison with Local Therapeutic Recommendations: A Population-Level Study on Utilization and Costs of Prescription DrugsAmir Hashemi-Meshkini, Reza Koochak, Shekoufeh Nikfar, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|January 29, 2013
Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?Khosro Keshavarz, Abbas Kebriaeezadeh, Amir Hashemi Meshkini, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|January 29, 2013
Assessment of the vaccine industry in Iran in context of accession to WTO: a survey studyAmir Hashemi Meshkini, Abbas Kebriaeezadeh, Rasoul Dinarvand, et al.
Archives of Medical Science : AMS|February 1, 2014
A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experienceKhosro Keshavarz, Amir Hashemi-Meshkini, Zahra Gharibnaseri, et al.
Archives of Medical Science : AMS|July 13, 2013
Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancerAmir Hashemi-Meshkini, Khosro Keshavarz, Zahra Gharibnaseri, et al.
BMC Health Services Research|March 15, 2023
Determinants and economic burden of HIV/AIDS in Iran: a prospective studyTahmineh Reshadat-Hajiabad, Alireza Khajavi, Ali Mohammad Hosseinpour, et al.
Value in Health Regional Issues|April 25, 2024
Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal PerspectiveMehdi Rezaee, Iman Karimzadeh, Amir Hashemi-Meshkini, et al.
Journal of Research in Pharmacy Practice|October 21, 2014
From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?Amir Hashemi-Meshkini, Mehdi Varmaghani, Mehdi Yousefi, et al.
Pageof 3